| Editor's Note: Nominations for Fierce Biotech's Fierce 15 close today. Submit yours now! |
Today's Big NewsJul 14, 2023 |
| By James Waldron Eli Lilly just can't get enough weight loss therapies or acquisitions to bolster its pipeline. The Indianapolis-based company has signed off on a $1.92 billion deal, which covers an upfront payment and potential milestones, for Boston-based Versanis and lead asset bimagrumab. |
|
|
|
By Conor Hale The three lawsuits allege Grail failed to properly respond to complaints of a “sexually charged” and hostile work environment. |
By Kevin Dunleavy As Johnson & Johnson awaits a decision on its second attempt to resolve talc lawsuits through a bankruptcy ploy, the company is attempting another legal tactic to help free itself from those liabilities—suing doctors who say that its iconic baby powder can cause cancer. |
By Max Bayer AAV-focused gene therapy maker Capsida Biotherapeutics is laying off staff, the company confirmed to Fierce Biotech. The cuts could impact as much as 25% of the team, a source familiar with the decision said. |
|
Thursday, July 20, 2023 | 12pm ET / 9am PT In this webinar, you will learn how to capture all healthcare services accurately using multiple datasets, the methodology to capture non-traditional HCP visits, what to look for in an affiliations dataset to help identify non-traditional HCP visits, and more. Register now.
|
|
By Zoey Becker One year after spinning out from GSK, consumer health business Haleon is looking to cut hundreds of jobs in the U.K. and potentially thousands worldwide as part of an effort to save 300 million pounds sterling over three years, The Guardian reports. |
By Andrea Park For BD, bad things seem to come in eights: The medtech giant issued a cybersecurity bulletin Thursday describing an octad of potential hacking risks it has discovered within certain versions of its Alaris infusion pump systems. |
By Annalee Armstrong CEL-SCI will need to conduct another clinical trial for its Multikine head and neck cancer drug—which the company has long trumpeted as a promising treatment, despite data that says otherwise. |
By Nick Paul Taylor GSK has reunited two stars of Sabrina the Teenage Witch for its latest meningitis awareness push. The centerpiece of the next phase of “Ask2BSure” campaign is a short Lifetime film that features Soleil Moon Frye and Melissa Joan Hart chatting about what moms of teens need to ask their children’s doctors. |
By Fraiser Kansteiner The potentially curative promise of gene therapies often carries a steep price tag. But for a pair of personalized medicine prospects in sickle cell disease (SCD), the cost could be worth it, at least as far as ICER is concerned. |
By Andrea Park A pair of recalls of devices made by Germany’s Dräger Medical and U.K.-based NOxBOX have each been given the FDA’s most serious Class I rating, the agency announced in separate notices this week. |
Fierce podcastsDon't miss an episode |
| | This week on "The Top Line," we discuss the state of digital phenotyping, plus the vaccine patent lawsuits, the smallest insulin pump, and the rest of the week's headlines. |
|
|---|
|
|
|
Tuesday, July 25, 2023 1pm ET / 10am PT New methods in scalable compute cloud environments not only accelerate drug discovery in a cost-effective manner, but benefit from reduced deployment time, accelerated GPU speed, and reduced infrastructure costs. Register now to learn more.
|
|
| ResearchThe right sourcing strategy can help save of millions of dollars—learn about developing a strategy for sourcing the cGMP chemicals critical to your processes. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| WhitepaperLearn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
| eBookThis eBook identifies the trends driving major change in the Medical Affairs (MA) function. It also outlines the strategic and tactical implications for MA leaders and team members. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| eBookTake a look at the reporting tools sponsors need to access insights earlier in the clinical trial enrollment funnel, so you can take informed actions. Sponsored by: OneStudyTeam |
| WhitepaperLearn how to develop a high-performing supply chain for cGMP chemicals used throughout your bioprocessing workflows. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| WhitepaperExplore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment. Sponsored by: Catalent Clinical Supply |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| |
|
